Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models.
Pang S, Li S, Cheng H, Luo Z, Qi X, Guan F, Dong W, Gao S, Liu N, Gao X, Pan S, Zhang X, Zhang L, Yang Y, Zhang L.
Pang S, et al. Among authors: zhang l, zhang x.
Front Mol Neurosci. 2023 Jan 9;15:1025066. doi: 10.3389/fnmol.2022.1025066. eCollection 2022.
Front Mol Neurosci. 2023.
PMID: 36698780
Free PMC article.